The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 301–400 of 1,000
Liu, Y., Li, X., Chen, Y., Yao, Q., Zhou, J., Wang, X., Meng, Q., Ji, J., Yu, Z., & Chen, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1556827 · Cited by 37
Self-citationMasetti, R., Zama, D., Leardini, D., Muratore, E., Turroni, S., Prete, A., Brigidi, P., & Pession, A. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28711 · Cited by 37
Fecal microbiota transplantation in hepatic encephalopathy: a systematic review
Madsen, M., Kimer, N., Bendtsen, F., & Petersen, A. M. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1899277 · Cited by 37
Hirano, R., Sakanaka, M., Yoshimi, K., Sugimoto, N., Eguchi, S., Yamauchi, Y., Nara, M., Maeda, S., Ami, Y., Gotoh, A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1973835 · Cited by 37
Guillot, N., Roméo, B., Manesh, S. S., Milano, G., Brest, P., Zitvogel, L., Hofman, P., & Mograbi, B. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.004 · Cited by 36
Immunological consequences of microbiome-based therapeutics
Alam, M. Z., Maslanka, J. R., & Abt, M. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1046472 · Cited by 38
Effects of Probiotic Supplementation on Exercise and the Underlying Mechanisms
Zhang, L., Zhang, R., & Li, L. (2023) · Foods · doi:10.3390/foods12091787 · Cited by 31
Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients—A Narrative Review
He, S., Lin, F., Hu, X., & Pan, P. (2023) · Nutrients · doi:10.3390/nu15224734 · Cited by 36
The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity
Zhuang, Z., Zhou, P., Wang, J., Lu, X., & Chen, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s432344 · Cited by 37
Self-citationSulaiman, J. E., Thompson, J. C., Qian, Y., Vivas, E. I., Diener, C., Gibbons, S. M., Safdar, N., & Venturelli, O. S. (2024) · Nature Communications · doi:10.1038/s41467-024-51062-w · Cited by 36
The gut microbiota in thrombosis
Khuu, M. P., Paeslack, N., Dremova, O., Benakis, C., Kiouptsi, K., & Reinhardt, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01070-6 · Cited by 36
Type 2 Diabetes and the Multifaceted Gut-X Axes
Guo, H., Pan, L.-T., Wu, Q., Wang, L., Huang, Z., Wang, J., Wang, L., Fang, X., Dong, S., Zhu, Y., et al. (2025) · Nutrients · doi:10.3390/nu17162708 · Cited by 38
Early development of the skin microbiome: therapeutic opportunities
Casterline, B. W., & Paller, A. S. (2020) · Pediatric Research · doi:10.1038/s41390-020-01146-2 · Cited by 39
Translational and clinical advances in acute graft-versus-host disease
Gooptu, M., & Koreth, J. (2020) · Haematologica · doi:10.3324/haematol.2019.240309 · Cited by 36
Klingensmith, N. J., & Coopersmith, C. M. (2023) · Surgical Infections · doi:10.1089/sur.2022.420 · Cited by 35
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Liu, Y., Xu, L., Yang, Z., Wang, D., Li, T., Yang, F., Li, Z., Bai, X., & Wang, Y.-C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114837 · Cited by 34
Mullish, B. H., Merrick, B., Quraishi, M. N., Bak, A., Green, C., Moore, D., Porter, R. J., Elumogo, N., Segal, J. P., Sharma, N., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331550 · Cited by 40
Intestinal biofilms: pathophysiological relevance, host defense, and therapeutic opportunities
Jandl, B., Dighe, S. N., Gasché, C., Makristathis, A., & Muttenthaler, M. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-23 · Cited by 36
Host–pathobiont interactions in Crohn’s disease
Caruso, R., Lo, B. C., Chen, G., & Núñez, G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00997-y · Cited by 35
Qi, X., Liu, M., Jiang, X., Gao, T., Xu, G., Zhang, H., Su, Q. Y., Du, Y., Luo, J., & Zhang, S. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103912 · Cited by 35
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era
Khanna, S., & Pardi, D. S. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000689 · Cited by 35
Biernat, M., Urbaniak-Kujda, D. M., Dybko, J., Kapelko-Slowik, K. L., Prajs, I., & Wróbel, T. (2020) · Journal of International Medical Research · doi:10.1177/0300060520925693 · Cited by 35
Benefits of fecal microbiota transplantation: A comprehensive review
Ademe, M. (2020) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.12780 · Cited by 37
Thänert, R., Thänert, A., Ou, J., Bajinting, A., Burnham, C. D., Engelstad, H. J., Tecos, M. E., Ndao, I. M., Hall-Moore, C. M., Rouggly-Nickless, C., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1940792 · Cited by 36
Intestinal barrier functions in hematologic and oncologic diseases
Haroun, E., Kumar, P. A., Saba, L., Kassab, J. T., Ghimire, K. B., Dutta, D., & Lim, S. H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04091-w · Cited by 36
Allegretti, J. R., Khanna, S., Mullish, B. H., & Feuerstadt, P. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.05.004 · Cited by 35
Olteanu, G., Pană, M.-A., Busnatu, Ș., Lupuliasa, D., Neacșu, S. M., Mititelu, M., Musuc, A. M., Ioniță-Mîndrican, C.-B., & Boroghină, S. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105561 · Cited by 36
Fecal microbiota transplantation, a tool to transfer healthy longevity
Novelle, M. G., Naranjo-Martínez, B., Lopez-Canovas, J. L., & Díaz‐Ruiz, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102585 · Cited by 35
Menon, R., Bhattarai, S. K., Crossette, E. M., Prince, A., Olle, B., Silber, J. L., Bucci, V., Faith, J. J., & Norman, J. M. (2025) · Nature Medicine · doi:10.1038/s41591-024-03337-4 · Cited by 35
Dolgin, E. (2020) · Nature · doi:10.1038/d41586-020-00199-x · Cited by 36
Henig, I. J., Yehudai‐Ofir, D., & Zuckerman, T. (2020) · Haematologica · doi:10.3324/haematol.2020.247395 · Cited by 34
Microbial orchestra in juvenile idiopathic arthritis: Sounds of disarray?
Arvonen, M., Vänni, P., Sarangi, A. N., Tejesvi, M. V., Vähäsalo, P., Aggarwal, A., & Stoll, M. L. (2019) · Immunological Reviews · doi:10.1111/imr.12826 · Cited by 34
Seven facts and five initiatives for gut microbiome research
Li, D., Gao, C., Zhang, F., Yang, R., Lan, C., Ma, Y., & Wang, J. (2020) · Protein & Cell · doi:10.1007/s13238-020-00697-8 · Cited by 36
Precision Microbiome: A New Era of Targeted Therapy with Core Probiotics
Fang, X., Wang, Y., Wei, H., & Huang, Y. (2025) · Research · doi:10.34133/research.0658 · Cited by 34
Yeh, Y., Cheng, H., Le, P., Chen, C.-C., Kuo, C., Chen, C., Chiu, C., & Chiu, C. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.06.001 · Cited by 33
Emerging Options for the Prevention and Management of Clostridioides difficile Infection
Gonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Drugs · doi:10.1007/s40265-022-01832-x · Cited by 33
Zhou, X., Wu, X., Wu, Y. T., Yang, L., Shi, E., Ding, W., Chen, L., Shi, X., Feng, X., Su, C., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005886 · Cited by 35
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 34
Gonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad642 · Cited by 35
Gynecological Cancers and Microbiota Dynamics: Insights into Pathogenesis and Therapy
Cocomazzi, G., Pup, L. D., Contu, V., Maggio, G., Parmegiani, L., Ciampaglia, W., Ruvo, D. D., Faioli, R., Maglione, A., Baldini, G. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042237 · Cited by 33
Integrative systems biology approaches for analyzing microbiome dysbiosis and species interactions
Rehman, S. S. U., Nasar, M. I., Mesquita, C. S., Khodor, S. A., Notebaart, R. A., Ott, S., Mundra, S., Arasardanam, R. P., Muhammad, K., & Alam, M. T. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf323 · Cited by 35
Role of gut microbiota and derived metabolites in cardiovascular diseases
Yu, J., Yang, Y., Chen, W., Hu, J., Jin, Z., Wu, C., & Li, Y. (2025) · iScience · doi:10.1016/j.isci.2025.113247 · Cited by 37
Merli, P., Putignani, L., Ruggeri, A., CHIERICO, F. D., Gargiullo, L., Galaverna, F., Gaspari, S., Pagliara, D., Russo, A., Pane, S., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.244210 · Cited by 33
The interplay of Clostridioides difficile infection and inflammatory bowel disease
Sehgal, K., Yadav, D., & Khanna, S. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211020285 · Cited by 33
Cruz, N., Abernathy, G. A., Dichosa, A. E. K., & Kumar, A. (2022) · Infection and Immunity · doi:10.1128/iai.00589-21 · Cited by 34
Nigam, M., Panwar, A. S., & SINGH, R. K. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.961569 · Cited by 33
Fecal Microbiota Transplantation: Tales of Caution
Khanna, S., & Kraft, C. S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1492 · Cited by 33
Mehta, N., Wang, T. L., Friedman‐Moraco, R., Carpentieri, C., Mehta, A. K., Rouphael, N., Dhere, T., Larsen, C. P., Kraft, C. S., & Woodworth, M. H. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00161-21 · Cited by 32
Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products
Brittain, N. Y., & Finbloom, J. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115663 · Cited by 34
Emerging role of microbiota in immunomodulation and cancer immunotherapy
Singh, R. P., Bashir, H., & Kumar, R. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.008 · Cited by 34
The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
Haifer, C., Leong, R. W. L., & Paramsothy, S. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.08.009 · Cited by 32
The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases
Liu, Y., Tran, D. Q., Lindsey, J. W., & Rhoads, J. M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_10 · Cited by 32
Berlanda, M., Innocente, G., Simionati, B., Camillo, B. D., Facchin, S., Giron, M. C., Savarino, E. V., Sebastiani, F., Fiorio, F., & Patuzzi, I. (2021) · Animals · doi:10.3390/ani11051433 · Cited by 32
Translating Microbiome Research From and To the Clinic
Zhang, Z. J., Lehmann, C. J., Cole, C. G., & Pamer, E. G. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-022206 · Cited by 33
Pilot evaluation of a single oral fecal microbiota transplantation for canine atopic dermatitis
Sugita, K., Shima, A., Takahashi, K., Ishihara, G., Kawano, K., & Ohmori, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-35565-y · Cited by 32
Jamal, R., Messaoudene, M., de Figuieredo, M., & Routy, B. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101754 · Cited by 31
Bajaj, J. S., Shamsaddini, A., Acharya, C., Fagan, A., Sikaroodi, M., Gavis, E. A., McGeorge, S., Khoruts, A., Fuchs, M. A., Sterling, R. K., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1993584 · Cited by 36
Slizovskiy, I. B., Oliva, M., Settle, J., Zyskina, L. V., Prosperi, M., Boucher, C. A., & Noyes, N. R. (2022) · Microbiome · doi:10.1186/s40168-022-01368-y · Cited by 31
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections
Benech, N., Barbut, F., Fitzpatrick, F., Krůtová, M., Davies, K., Druart, C., Cordaillat‐Simmons, M., Heritage, J. C., Guery, B. P., & Kuijper, E. J. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.12.007 · Cited by 31
Fecal microbiota transplantation: present and future
Cha, R. R., & Sonu, I. S. (2025) · Clinical Endoscopy · doi:10.5946/ce.2024.270 · Cited by 35
Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies
Huang, M., Zhang, Y., Chen, Z., Yu, X., Luo, S., Peng, X., & Li, X. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107726 · Cited by 31
Assa, A., Aloi, M., Biervliet, S. V., Bronský, J., de Carpi, J. M., Gasparetto, M., Gianolio, L., Gordon, H., Hojsak, I., Hudson, A. S., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70096 · Cited by 31
Fecal transplants as a microbiome-based therapeutic
Kaakoush, N. O. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.05.008 · Cited by 31
Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Peng, X., Parvathy, S. N., Chen, Y., Silverman, M., & Routy, J. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00421 · Cited by 31
Self-citationFecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century
El‐Salhy, M., Patcharatrakul, T., & Gonlachanvit, S. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i22.2921 · Cited by 33
Lei, J., Xie, Y., Sheng, J., & Song, J. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2056054 · Cited by 31
Microbiota-targeted therapies in inflammation resolution
Strati, F., Lattanzi, G., Amoroso, C., & Facciotti, F. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101599 · Cited by 31
The Role of Short-Chain Fatty Acids in Acute Pancreatitis
Yan, X., Li, J., & Wu, D. (2023) · Molecules · doi:10.3390/molecules28134985 · Cited by 30
The practice of fecal microbiota transplantation in inflammatory bowel disease
Arora, U., Kedia, S., & Ahuja, V. (2023) · Intestinal Research · doi:10.5217/ir.2023.00085 · Cited by 32
The role of microbiomes in gastrointestinal cancers: new insights
Yarahmadi, A., & Afkhami, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1344328 · Cited by 30
DeFilipp, Z. M., Damania, A. V., Kim, H. T., Chang, C., El-Jawahri, A. R., McAfee, S. L., Bottoms, A. S., Toncheva, V., Smith, M. M., Dolaher, M., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024012556 · Cited by 30
Self-citationRecurrent Clostridioides difficile infection: Recognition, management, prevention
Tsigrelis, C. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87gr.20001 · Cited by 30
Kragsnæs, M. S., Nilsson, A. C., Kjeldsen, J., Holt, H. M., Rasmussen, K. F., Georgsen, J., Ellingsen, T., & Holm, D. K. (2020) · Transfusion · doi:10.1111/trf.15816 · Cited by 30
Alagna, L., Palomba, E., Mangioni, D., Bozzi, G., Lombardi, A., Ungaro, R., Castelli, V., Prati, D., Vecchi, M. L., Muscatello, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165619 · Cited by 31
Gut microbiome and nonalcoholic fatty liver disease
Wu, M., & Fan, J. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.06.006 · Cited by 32
Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease
Giuli, L., Maestri, M., Santopaolo, F., Pompili, M., & Ponziani, F. R. (2023) · Metabolites · doi:10.3390/metabo13060772 · Cited by 30
Kisthardt, S. C., Thanissery, R., Pike, C. M., Foley, M. H., & Theriot, C. M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00180-23 · Cited by 29
Juhász, J., Ligeti, B., Gajdács, M., Makra, N., Ostorházi, E., Farkas, F. B., Stercz, B., Tóth, Á., Domokos, J., Pongor, S., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10030268 · Cited by 29
Microbiome Therapeutics for Food Allergy
Chernikova, D. A., Zhao, M. Y., & Jacobs, J. P. (2022) · Nutrients · doi:10.3390/nu14235155 · Cited by 30
Borgers, J. S. W., Burgers, F. H., Terveer, E. M., van Leerdam, M. E., Korse, C. M., Kessels, R., Flohil, C. C., Blank, C. U., Schumacher, T. N., van Dijk, M., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-10457-y · Cited by 29
Bainum, T. B., Reveles, K. R., Hall, R. G., Cornell, K., & Álvarez, C. A. (2023) · Microorganisms · doi:10.3390/microorganisms11020387 · Cited by 29
Gurung, B., Stricklin, M. L., & Wang, S. (2024) · Metabolites · doi:10.3390/metabo14010074 · Cited by 28
Microbial Symphony: Exploring the Role of the Gut in Osteoarthritis-Related Pain. A Narrative Review
Corriero, A., Giglio, M., Soloperto, R., Inchingolo, F., Varrassi, G., & Puntillo, F. (2024) · Pain and Therapy · doi:10.1007/s40122-024-00602-9 · Cited by 28
Roy, S., Bahmani, A. H. A., Davids, M., Herrema, H., & Nieuwdorp, M. (2025) · Microorganisms · doi:10.3390/microorganisms13061356 · Cited by 28
Probiotics: Promise, Evidence, and Hope
Khoruts, A., Hoffmann, D. E., & Britton, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.05.058 · Cited by 28
The gut microbiota and gut disease
Fehily, S. R., Basnayake, C., Wright, E. K., & Kamm, M. A. (2021) · Internal Medicine Journal · doi:10.1111/imj.15520 · Cited by 30
New perspective on fecal microbiota transplantation in liver diseases
Suk, K. T., & Koh, H. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15729 · Cited by 28
Merali, N., Chouari, T. A. M., Kayani, K., Rayner, C. J., Jiménez, J. I., Krell, J., Giovannetti, E., Bagwan, I., Relph, K., Rockall, T., et al. (2022) · Cancers · doi:10.3390/cancers14041020 · Cited by 29
Donnell, M. M. O., Hegarty, J. W., Healy, B., Schulz, S., Walsh, C. J., Hill, C., Ross, R. P., Rea, M. C., Farquhar, R., & Chesnel, L. (2022) · Scientific Reports · doi:10.1038/s41598-022-13248-4 · Cited by 28
Zhang, S., Deng, F., Chen, J., Chen, F., Wu, Z., Li, L., & Hou, K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1075201 · Cited by 30
Drug-Resistant Bacteremia after Fecal Microbiota Transplant
Bleibtreu, A., Kapel, N., & Galpérine, T. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2002496 · Cited by 28
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 28
The role of the early-life gut microbiome in childhood asthma
Boulund, U., Thorsen, J., Trivedi, U., Tranæs, K., Jiang, J., Shah, S. A., & Stokholm, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2457489 · Cited by 30
Cancer and immunotherapy: a role for microbiota composition
Pham, F., Moinard‐Butot, F., Coutzac, C., & Chaput, N. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.051 · Cited by 28
Cold, F., Svensson, C. K., Petersen, A. M., Hansen, L. H., & Helms, M. (2022) · Cells · doi:10.3390/cells11030435 · Cited by 27
Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
Bae, J., Park, K., & Kim, Y. (2022) · Immune Network · doi:10.4110/in.2022.22.e3 · Cited by 30
Zhang, Y., Fleur, A. S., & Feng, H. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2052698 · Cited by 27
Conover, K. R., Absah, I., Ballal, S. A., Brumbaugh, D. E., Cho, S., Cardenas, M. C., Knackstedt, E. D., Goyal, A., Jensen, M. K., Kaplan, J. L., et al. (2023) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003714 · Cited by 27
Li, T., Han, L., Ma, S., Lin, W., Ba, X. W., Yan, J., Huang, Y., Tu, S., & Qin, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1140325 · Cited by 27
Host Immunity and Immunization Strategies for Clostridioides difficile Infection
Naz, F., & Petri, W. A. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00157-22 · Cited by 27
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
